159 related articles for article (PubMed ID: 22976848)
1. Brain organochlorines and Lewy pathology: the Honolulu-Asia Aging Study.
Ross GW; Duda JE; Abbott RD; Pellizzari E; Petrovitch H; Miller DB; O'Callaghan JP; Tanner CM; Noorigian JV; Masaki K; Launer L; White LR
Mov Disord; 2012 Sep; 27(11):1418-24. PubMed ID: 22976848
[TBL] [Abstract][Full Text] [Related]
2. Association of brain heptachlor epoxide and other organochlorine compounds with lewy pathology.
Ross GW; Abbott RD; Petrovitch H; Duda JE; Tanner CM; Zarow C; Uyehara-Lock JH; Masaki KH; Launer LJ; Studabaker WB; White LR
Mov Disord; 2019 Feb; 34(2):228-235. PubMed ID: 30597605
[TBL] [Abstract][Full Text] [Related]
3. Midlife milk consumption and substantia nigra neuron density at death.
Abbott RD; Ross GW; Petrovitch H; Masaki KH; Launer LJ; Nelson JS; White LR; Tanner CM
Neurology; 2016 Feb; 86(6):512-9. PubMed ID: 26658906
[TBL] [Abstract][Full Text] [Related]
4. Bowel movement frequency in late-life and incidental Lewy bodies.
Abbott RD; Ross GW; Petrovitch H; Tanner CM; Davis DG; Masaki KH; Launer LJ; Curb JD; White LR
Mov Disord; 2007 Aug; 22(11):1581-6. PubMed ID: 17523195
[TBL] [Abstract][Full Text] [Related]
5. Lewy body-related alpha-synucleinopathy in the aged human brain.
Jellinger KA
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
[TBL] [Abstract][Full Text] [Related]
6. Association of olfactory dysfunction with incidental Lewy bodies.
Ross GW; Abbott RD; Petrovitch H; Tanner CM; Davis DG; Nelson J; Markesbery WR; Hardman J; Masaki K; Launer L; White LR
Mov Disord; 2006 Dec; 21(12):2062-7. PubMed ID: 16991138
[TBL] [Abstract][Full Text] [Related]
7. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
8. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
[TBL] [Abstract][Full Text] [Related]
9. Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies.
White LR; Edland SD; Hemmy LS; Montine KS; Zarow C; Sonnen JA; Uyehara-Lock JH; Gelber RP; Ross GW; Petrovitch H; Masaki KH; Lim KO; Launer LJ; Montine TJ
Neurology; 2016 Mar; 86(11):1000-8. PubMed ID: 26888993
[TBL] [Abstract][Full Text] [Related]
10. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.
Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K
J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247
[TBL] [Abstract][Full Text] [Related]
11. Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?
Frigerio R; Fujishiro H; Ahn TB; Josephs KA; Maraganore DM; DelleDonne A; Parisi JE; Klos KJ; Boeve BF; Dickson DW; Ahlskog JE
Neurobiol Aging; 2011 May; 32(5):857-63. PubMed ID: 19560232
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
13. Non-uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies.
Yamamoto R; Iseki E; Marui W; Togo T; Katsuse O; Kato M; Isojima D; Akatsu H; Kosaka K; Arai H
Neuropathology; 2005 Sep; 25(3):188-94. PubMed ID: 16193834
[TBL] [Abstract][Full Text] [Related]
14. Regional Overlap of Pathologies in Lewy Body Disorders.
Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
[TBL] [Abstract][Full Text] [Related]
15. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.
Zaccai J; Brayne C; McKeith I; Matthews F; Ince PG;
Neurology; 2008 Mar; 70(13):1042-8. PubMed ID: 18362284
[TBL] [Abstract][Full Text] [Related]
16. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants.
White L; Petrovitch H; Hardman J; Nelson J; Davis DG; Ross GW; Masaki K; Launer L; Markesbery WR
Ann N Y Acad Sci; 2002 Nov; 977():9-23. PubMed ID: 12480729
[TBL] [Abstract][Full Text] [Related]
18. α-Synuclein and Lewy pathology in Parkinson's disease.
Kalia LV; Kalia SK
Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases.
Kon T; Tomiyama M; Wakabayashi K
Neuropathology; 2020 Feb; 40(1):30-39. PubMed ID: 31498507
[TBL] [Abstract][Full Text] [Related]
20. Lewy body pathology in Alzheimer's disease.
Kotzbauer PT; Trojanowsk JQ; Lee VM
J Mol Neurosci; 2001 Oct; 17(2):225-32. PubMed ID: 11816795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
